Russell Investments Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $124M | Buy |
2,895,696
+577,276
| +25% | +$31.3M | 0.11% | 181 |
|
|
2026
Q1 | $146M | Buy |
2,318,420
+372,845
| +19% | +$29.8M | 0.16% | 126 |
|
|
2025
Q4 | $186M | Buy |
1,945,575
+291,108
| +18% | +$28.5M | 0.2% | 84 |
|
|
2025
Q3 | $161M | Buy |
1,654,467
+211,827
| +15% | +$21.9M | 0.18% | 100 |
|
|
2025
Q2 | $155M | Buy |
1,442,640
+120,648
| +9% | +$12.2M | 0.2% | 90 |
|
|
2025
Q1 | $133M | Buy |
1,321,992
+225,678
| +21% | +$22.7M | 0.18% | 110 |
|
|
2024
Q4 | $98M | Buy |
1,096,314
+111,991
| +11% | +$9.86M | 0.14% | 150 |
|
|
2024
Q3 | $82.4M | Buy |
984,323
+196,414
| +25% | +$15.5M | 0.12% | 184 |
|
|
2024
Q2 | $60.7M | Buy |
787,909
+14,287
| +2% | +$1.05M | 0.1% | 214 |
|
|
2024
Q1 | $53M | Buy |
773,622
+31,853
| +4% | +$2.05M | 0.08% | 263 |
|
|
2023
Q4 | $42.7M | Buy |
741,769
+122,979
| +20% | +$6.56M | 0.08% | 284 |
|
|
2023
Q3 | $32.7M | Sell |
618,790
-57,160
| -8% | -$3M | 0.06% | 326 |
|
|
2023
Q2 | $36.6M | Sell |
675,950
-208,229
| -24% | -$10.9M | 0.07% | 311 |
|
|
2023
Q1 | $44.2M | Sell |
884,179
-127,508
| -13% | -$6.01M | 0.09% | 268 |
|
|
2022
Q4 | $46.8M | Buy |
1,011,687
+58,344
| +6% | +$2.53M | 0.1% | 261 |
|
|
2022
Q3 | $36.9M | Buy |
953,343
+508,181
| +114% | +$20.4M | 0.08% | 293 |
|
|
2022
Q2 | $16.6M | Sell |
445,162
-235,447
| -35% | -$9.58M | 0.03% | 574 |
|
|
2022
Q1 | $30.1M | Sell |
680,609
-24,099
| -3% | -$1.04M | 0.05% | 427 |
|
|
2021
Q4 | $29.9M | Sell |
704,708
-211,062
| -23% | -$8.87M | 0.05% | 464 |
|
|
2021
Q3 | $39.7M | Buy |
915,770
+502,589
| +122% | +$22.2M | 0.07% | 353 |
|
|
2021
Q2 | $17.7M | Buy |
413,181
+12,290
| +3% | +$517K | 0.03% | 658 |
|
|
2021
Q1 | $15.5M | Buy |
400,891
+6,761
| +2% | +$256K | 0.03% | 700 |
|
|
2020
Q4 | $14.1M | Sell |
394,130
-164,145
| -29% | -$5.92M | 0.03% | 664 |
|
|
2020
Q3 | $21.3M | Sell |
558,275
-7,978
| -1% | -$307K | 0.05% | 462 |
|
|
2020
Q2 | $19.9M | Buy |
566,253
+82,844
| +17% | +$2.98M | 0.04% | 463 |
|
|
2020
Q1 | $15.7M | Buy |
483,409
+65,207
| +16% | +$2.55M | 0.04% | 477 |
|
|
2019
Q4 | $18.9M | Buy |
418,202
+12,091
| +3% | +$506K | 0.04% | 567 |
|
|
2019
Q3 | $16.5M | Sell |
406,111
-57,432
| -12% | -$2.43M | 0.03% | 626 |
|
|
2019
Q2 | $19.9M | Buy |
463,543
+41,420
| +10% | +$1.59M | 0.04% | 569 |
|
|
2019
Q1 | $16.2M | Buy |
422,123
+117,022
| +38% | +$4.47M | 0.03% | 662 |
|
|
2018
Q4 | $10.8M | Sell |
305,101
-5,852
| -2% | -$212K | 0.02% | 767 |
|
|
2018
Q3 | $12M | Sell |
310,953
-14,959
| -5% | -$522K | 0.02% | 830 |
|
|
2018
Q2 | $10.6M | Sell |
325,912
-121,607
| -27% | -$3.67M | 0.02% | 879 |
|
|
2018
Q1 | $12.2M | Sell |
447,519
-694,478
| -61% | -$18.9M | 0.02% | 872 |
|
|
2017
Q4 | $28.8M | Sell |
1,141,997
-122,880
| -10% | -$3.39M | 0.05% | 459 |
|
|
2017
Q3 | $36.9M | Buy |
1,264,877
+274,893
| +28% | +$7.59M | 0.06% | 370 |
|
|
2017
Q2 | $27.4M | Buy |
989,984
+189,132
| +24% | +$5.02M | 0.05% | 474 |
|
|
2017
Q1 | $19.9M | Sell |
800,852
-232,041
| -22% | -$5.64M | 0.04% | 571 |
|
|
2016
Q4 | $22.4M | Buy |
+1,032,893
| New | +$22.5M | 0.04% | 499 |
|
Other funds holding BSX
Russell Investments Group's BSX Position: Q2 2026 in Review
Russell Investments Group increased its Boston Scientific (BSX) stake by 25% in Q2 2026, buying an estimated $31.3M and bringing the position to 2,895,696 shares worth $124M. The position accounts for 0.11% of the portfolio, ranked #181.
Russell Investments Group first reported a position in BSX in Q4 2016 and has held it in 39 quarters since. The position peaked at $186M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Russell Investments Group held 2,895,696 shares of Boston Scientific worth $124M as of Q2 2026.
- Russell Investments Group bought 577,276 Boston Scientific shares in Q2 2026, an estimated $31.3M.
- Boston Scientific made up 0.11% of Russell Investments Group's portfolio in Q2 2026, its #181 holding.
- Russell Investments Group first reported a position in Boston Scientific in Q4 2016 and has held it in 39 quarters since.
- Russell Investments Group's Boston Scientific position peaked at $186M in Q4 2025.
- 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.